Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
10/05/2000 | CA2368641A1 Use of a lectin or conjugates for modulation of c-fibre activity |
10/05/2000 | CA2368469A1 50 human secreted proteins |
10/05/2000 | CA2368467A1 50 human secreted proteins |
10/05/2000 | CA2368463A1 Phosphate containing macrocyclic immunomodulators |
10/05/2000 | CA2368442A1 48 human secreted proteins |
10/05/2000 | CA2368302A1 49 human secreted proteins |
10/05/2000 | CA2368090A1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
10/05/2000 | CA2366305A1 Method for expressing proteins |
10/05/2000 | CA2365401A1 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands |
10/05/2000 | CA2362409A1 Sulfamate containing macrocyclic immunomodulators |
10/05/2000 | CA2362388A1 Dermatological topical composition |
10/05/2000 | CA2361366A1 Novel compounds |
10/05/2000 | CA2329261A1 Susceptibility to psoriasis |
10/04/2000 | EP1041072A1 Dioxocyclopentyl hydroxamic acids |
10/04/2000 | EP1041068A1 Compounds for treating and preventing diabetic complications |
10/04/2000 | EP1040838A1 Stable aqueous EM 12 solution |
10/04/2000 | EP1040822A1 Extensible Mask with an adhesive matrix which is at least stretchable when wetted |
10/04/2000 | EP1040112A1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
10/04/2000 | EP1040111A1 Integrin receptor antagonists |
10/04/2000 | EP1040100A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors |
10/04/2000 | EP1040099A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals |
10/04/2000 | EP1040098A1 Integrin receptor antagonists |
10/04/2000 | EP1039932A1 Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions |
10/04/2000 | EP1039929A1 Activated t-cells and their uses |
10/04/2000 | EP1039916A2 Use of fucane for regulating the reconstruction of connective tissues |
10/04/2000 | EP1039904A1 Synergistic antimicrobial compositions |
10/04/2000 | EP1039903A1 Il-8 receptor antagonists |
10/04/2000 | EP1039891A1 Treatment of scar tissue using lipoic acid |
10/04/2000 | EP1039874A1 Compositions and methods for treatment of alopecia |
10/04/2000 | EP1039804A1 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation |
10/04/2000 | EP1019040A4 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS |
10/04/2000 | EP0772610B1 Dihydrobenzofuranes |
10/04/2000 | CN1268889A Novel process for obtg. intermediates |
10/04/2000 | CN1268887A Pharmaceutical compositions for treatment of psoriasis |
10/04/2000 | CN1268886A Treatment of cell-mediated immune diseases |
10/04/2000 | CN1268348A Skin-care prepns. for fair-skinned face |
10/04/2000 | CN1057090C Novel derivative of kojic acid and its use as depigmenting agent |
10/04/2000 | CN1057010C Chinese medicine oil prepn. for treating burns and scalds and its prepn. method |
10/04/2000 | CN1056995C Spray for burn and scald and prepn. method therefor |
10/04/2000 | CN1056993C Ointment for skin-protection after being burned |
10/04/2000 | CN1056987C Medicine for curing viral warts |
10/04/2000 | CN1056978C Method or preparing patent traditional Chinese medicine for external application 'Baxianzhi', 'Baxianhu' contg. eight fresh herb medicines |
10/04/2000 | CN1056977C Multi-funcition medicine for curing frostbite |
10/03/2000 | US6127559 2-alkyl-19-nor-vitamin D compounds |
10/03/2000 | US6127426 Antiallergic and -inflammatory agents e.g., treating psoriasis, blocked on the c-10 by a nonphenolic arylacyl or a phenylalkylidene group; lipoxygenase inhibitors; antiproliferative agents; low dosage; side effect reduction |
10/03/2000 | US6127423 Phenylamidine derivatives, a process for preparing the same and their use as medicaments |
10/03/2000 | US6127401 Treatment of prostate disorders, angiogenic disorders, neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease |
10/03/2000 | US6127387 Use of CD4-binding small molecules to inhibit immune responses |
10/03/2000 | US6127382 An antiproliferative agent for treating skin-related diseases, an antitumor agent treating cancer, an antiinflammatory agent treating pulmonary fibrosis, ileitis, colitis and krohn's disease |
10/03/2000 | US6127348 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
10/03/2000 | US6127143 Preparation of purified and biocompatible collagen using two proteolytic enzyme treatments and a reducing agent |
10/03/2000 | US6126962 Crystalline powdery saccharide, its preparation and uses |
10/03/2000 | US6126948 Stable oil-in-water emulsion, process for its manufacture and its use in the cosmetic and dermatological fields |
10/03/2000 | US6126947 Method for the treatment of skin disorders using inhibitor of cholesterol synthesis |
10/03/2000 | US6126939 Anti-inflammatory dipeptide and pharmaceutical composition thereof |
10/03/2000 | US6126935 Pellets obtained from cell cultures of keratinocytes and their use in wound healing |
10/03/2000 | US6126917 Epidermal growth factor receptor binding compounds for positron emission tomography |
09/30/2000 | CA2302886A1 A stable aqueous solution of em 12 |
09/28/2000 | WO2000057190A2 Prediction of diabetes impaired wound healing |
09/28/2000 | WO2000056910A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites |
09/28/2000 | WO2000056891A2 Human transmembrane proteins |
09/28/2000 | WO2000056889A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
09/28/2000 | WO2000056882A1 48 human secreted proteins |
09/28/2000 | WO2000056881A1 48 human secreted proteins |
09/28/2000 | WO2000056880A1 50 human secreted proteins |
09/28/2000 | WO2000056862A1 Human tumor necrosis factor receptor tr9 |
09/28/2000 | WO2000056772A1 Human antibodies that bind human il-12 and methods for producing |
09/28/2000 | WO2000056771A1 Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders |
09/28/2000 | WO2000056767A1 46 human secreted proteins |
09/28/2000 | WO2000056765A1 48 human secreted proteins |
09/28/2000 | WO2000056755A1 49 human secreted proteins |
09/28/2000 | WO2000056754A1 48 human secreted proteins |
09/28/2000 | WO2000056753A1 49 human secreted proteins |
09/28/2000 | WO2000056751A1 50 human secreted proteins |
09/28/2000 | WO2000056738A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
09/28/2000 | WO2000056729A1 Chemokine recpetor binding heterocyclic compounds |
09/28/2000 | WO2000056710A1 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors |
09/28/2000 | WO2000056709A1 Indolinone compounds as kinase inhibitors |
09/28/2000 | WO2000056704A1 Hydroxamic and carboxylic acid derivatives |
09/28/2000 | WO2000056702A1 Resorcinol derivatives |
09/28/2000 | WO2000056438A1 Novel stable water-in-oil emulsions containing an emulsifier based on oleyl- and/or isostearyl-glycoside |
09/28/2000 | WO2000056403A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS |
09/28/2000 | WO2000056363A1 Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist |
09/28/2000 | WO2000056350A2 Methods of use of beta 1-integrin inhibitors |
09/28/2000 | WO2000056349A1 Treatment with small peptides to effect antifibrotic activity |
09/28/2000 | WO2000056345A2 Methods for limiting scar and adhesion formation |
09/28/2000 | WO2000056327A1 Ascorbic acid composition and method for treatment of aging or damaged skin |
09/28/2000 | WO2000056304A2 Anti-inflammatory uses of manzamines |
09/28/2000 | WO2000056279A1 Resorcinol composition |
09/28/2000 | WO2000056278A1 Use of vitamin c or the like for stimulating skin cell synthesis |
09/28/2000 | WO2000056275A1 Compositions based on chondroitin sulphate and chitosan for preventing or treating rheumatic disorders by general administration |
09/28/2000 | WO2000041545A3 Regulators of the pct or smoothened pathway, compositions and uses related thereto |
09/28/2000 | WO2000035428A3 Tricyclic nitrogen heterocycles as pde iv inhibitors |
09/28/2000 | WO2000022143A3 Protein kinase homologs |
09/28/2000 | WO2000020447A3 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
09/28/2000 | WO2000015793A3 Human gpcr proteins |
09/28/2000 | DE19851334C2 Flexible Wundauflage auf Fibrinbasis und Verfahren zu ihrer Herstellung Flexible wound covering based on fibrin, and processes for their preparation |
09/28/2000 | CA2669512A1 Human antibodies that bind human il-12 and methods for producing |
09/28/2000 | CA2442340A1 Methods for limiting scar and adhesion formation |
09/28/2000 | CA2368916A1 49 human secreted proteins |